Acupuncture for the anxiety and depression in Parkinson disease: A systematic review and network meta-analysis.

Researchers analyzed 26 studies involving 2,153 patients with Parkinson's disease who experienced anxiety or depression. Parkinson's disease is known for causing movement problems, but many patients also struggle with emotional symptoms that can worsen as the disease progresses. This research examined whether acupuncture could help relieve these emotional challenges.

The study compared different treatment approaches: acupuncture combined with Western medications, acupuncture alone, and Western medications alone. Researchers used established measurement scales to track improvements in depression and anxiety symptoms across all the studies.

The findings showed that combining acupuncture with Western medications produced better results than using Western medications alone. This combination approach showed the most significant improvements in depression scores measured by the Hamilton Depression Rating Scale, as well as improvements in anxiety scores and self-reported depression levels. When acupuncture was combined with both traditional Chinese medicine and Western medicine, patients also experienced better reductions in self-reported anxiety compared to Western medicine alone.

For patients with Parkinson's disease struggling with anxiety or depression, these results suggest that adding acupuncture to conventional medical treatment may offer additional relief. The study indicates acupuncture works best as a complementary therapy rather than a replacement for standard medications. However, the researchers noted that some limitations in study quality mean more research is needed to confirm these findings. If you're considering acupuncture for Parkinson's-related anxiety or depression, discuss it with your neurologist and seek treatment from a licensed acupuncturist experienced in treating neurological conditions.

This systematic review and network meta-analysis evaluated acupuncture's efficacy for anxiety and depression in Parkinson's disease patients. Twenty-six randomized controlled trials involving 2,153 PD patients were analyzed using STATA 17.0 for network meta-analysis and RevMan 5.4 for pairwise comparisons. Outcome measures included HAMD, HAMA, SDS, and SAS scores.

Network meta-analysis demonstrated that acupuncture combined with Western medicine showed superior efficacy compared to other interventions in reducing HAMD, HAMA, and SDS scores. Acupuncture combined with both traditional Chinese medicine and Western medicine yielded better SAS score improvements than Western medicine monotherapy.

Clinical implications suggest acupuncture as an adjunctive therapy to conventional pharmacotherapy may optimize treatment outcomes for PD-related mood disorders. The integration of acupuncture appears more effective than either modality alone. However, the authors acknowledge methodological limitations in included studies and risk of bias concerns, warranting cautious interpretation. Future high-quality RCTs with standardized acupuncture protocols and longer follow-up periods are needed to establish definitive clinical guidelines for this patient population.